Category Archives: clinical trials

Five Reasons Why mHealth is Not Going Away (Despite the Hype-Haters)

Posted on June 18, 2024 by

One feels almost assaulted by financial projections of the mHealth market every day. Extrapolations from the increasing use of smartphones, the use of iPads by physicians, the adoption of patient portals by insurers, research of the Internet for medical purposes … Continue reading →

Posted in clinical trials, digital health, healthcare economics, Healthcare IT, healthcare reform, medical apps, mobile health, smartphone apps, technology, telehealth, wireless health | Tagged , , , , , , , , | 1 Comment

Five Reasons Why Digital Health Technologies Need FDA Oversight

Posted on June 12, 2024 by

A draft proposal of the FDA guidelines for regulating mobile medical applications was released in July, 2011. In response, the mHealth Regulatory Coalition sent detailed comments on the proposal (http://mhealthregulatorycoalition.org/wp-content/uploads/2010/06/MRC-Comments-on-FDA-Draft-MMA-Guidance.pdf). There was a recent piece in the Washington Times “The … Continue reading →

Posted in clinical trials, digital health, healthcare economics, Healthcare IT, healthcare reform, informatics, medical devices, mHealth, mobile health, pharma, smartphone apps, technology, telehealth, wireless health | 4 Comments

Five Ways to get Physicians to Adopt Digital Health Technologies

Posted on June 11, 2024 by

1. Make it worth doing. Until the fee for service reimbursement model goes away, the request to adopt any new technology by physicians is met with the question, “Is this a reimbursable service?” This is a sad but true state … Continue reading →

Posted in clinical trials, digital health, Healthcare IT, informatics, mobile health, smartphone apps, technology, wireless health | Tagged , , , , , , , , , , , | 2 Comments

Five Reasons Why Pharma Needs Mobile Apps

Posted on June 5, 2024 by

While Pharma companies are dabbling in social media, the importance of a strong presence in mobile health technologies cannot be ignored. Here are some reasons: 1. Mobile apps are not a passing fad and Pharma needs to be … Continue reading →

Posted in clinical trials, digital health, education, Healthcare IT, medical education, mHealth, mobile health, pharma, technology, telehealth, wireless health | Tagged , , , , , , , , | 2 Comments

Is Telemedicine Good or Bad For Us?

Posted on April 21, 2024 by

Telemedicine, as defined by the American Telemedicine Association is: “the use of medical information exchanged from one site to another via electronic communications to improve patients’ health status.” Multiple factors are driving the attraction of telemedicine. The ACA paving the … Continue reading →

Posted in clinical trials, healthcare economics, Healthcare IT, healthcare reform, media coverage, mHealth, mobile health, smartphone apps, technology, telehealth, wireless health | Tagged , , , , , , , , , , , | Leave a comment

Five Reasons Why Insurers are Key to mHealth Adoption

Posted on April 9, 2024 by

I have talked about some of the major stakeholders in mHealth adoption, what technology companies need to consider when developing and marketing to them, why mhealth will be important to the various stakeholders, and why the stakeholders are, in turn, … Continue reading →

Posted in clinical trials, digital health, health insurance, healthcare economics, Healthcare IT, healthcare reform, informatics, mHealth, mobile health, technology, telehealth, wireless health | Tagged , , , , , , , , , , , , , , | 1 Comment

Crowdsource-derived Data for Post-Market Surveillance of Drugs and Medical Devices

Posted on April 5, 2024 by

Recently,Oregon’s Senator Jeff Merkley, with Senators Chuck Grassley (R-IA), Michael Bennet (D-CO) and Herb Kohl (D-WI), introduced the bipartisan Ensuring Safe Medical Devices for Patients Act. It requires the FDA to issue a Unique Device Identifier rule by the end … Continue reading →

Posted in clinical trials, digital health, FDA, mobile health, wireless health | Tagged , , , , , , , | 1 Comment

Crowdsourced Clinical Studies: A New Paradigm in Health Care?

Posted on March 30, 2024 by

The Miriam-Webster defines crowdsourcing as: “the practice of obtaining participants, services, ideas, or content by soliciting contributions from a large group of people, especially via the Internet.” Clinical studies using patient recruitment and data collected via crowdsourcing is surely an … Continue reading →

Posted in clinical trials, digital health, education, FDA, healthcare reform, mobile health, pharma, technology, wireless health | Tagged , , , , , , , , | Leave a comment

mHealth and Pharma: Opportunities for Patients and Industry

Posted on March 28, 2024 by

No greater is the opportunity for mHealth to break into mainstream healthcare than in partnerships with members of the pharmaceutical community. mHealth’s influence in the sector may be tentacle in the patient care area, the business process area, and the … Continue reading →

Posted in clinical trials, digital health, healthcare economics, Healthcare IT, informatics, mHealth, mobile health, pharma, smartphone apps, wireless health | Tagged , , , , , , , | 1 Comment

Adoption of mHealth: Chicken or Egg?

Posted on March 21, 2024 by

There seems to be universal agreement among all stakeholders in health care that mHealth technologies will play a significant role in the future. The questions are how far into the future and how will they find their way to patients. … Continue reading →

Posted in clinical trials, digital health, education, FDA, Healthcare IT, healthcare reform, informatics, mHealth, mobile health, smartphone apps, technology, telehealth, wireless health | Tagged , , , , , , , , , , , , , | Leave a comment